Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Headwaters Capital. This analysis is provided for institutional research purposes only and is not investment advice.
"Headwaters Capital remains cautious of a 1999-style speculative AI bubble, instead deploying capital into deeply discounted, high-quality small-cap stocks like Bio-Techne (TECH) to capture an impending market rotation."
In Q2 2025, Headwaters Capital gained +7.5% gross (+7.3% net) compared to a +8.5% gain for the Russell Mid Cap Index. The manager outlines deep concerns about the current market environment, comparing the extreme concentration and speculation in AI, crypto, and meme stocks to the 1999 bubble. Because of this focus on momentum, the rest of the market—specifically high-quality small caps—has been completely ignored, presenting a historically attractive valuation opportunity. Within the portfolio, Transmedics (TMDX) was sold for an 85% return to manage rising competitive risks and valuation, while Bio-Techne (TECH) was added as a new high-quality core holding trading at trough levels due to temporary worries over US academic NIH funding cuts.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Headwaters Capital remains cautious of a 1999-style speculative AI bubble, instead deploying capital into deeply discounted, high-quality small-cap stocks like Bio-Techne (TECH) to...
Growth Outlook
Market outlook remains moderate conviction: Headwaters Capital remains cautious of a 1999-style speculative AI bubble, instead deploying capital into deeply discounted, high-quality small-cap stocks like Bio-Techne (TECH) to...
Risk Appetite
Risk appetite posture is low conviction: Headwaters Capital remains cautious of a 1999-style speculative AI bubble, instead deploying capital into deeply discounted, high-quality small-cap stocks like Bio-Techne (TECH) to...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Headwaters Capital remains cautious of a 1999-style speculative AI bubble, instead deploying capital into deeply discounted, high-quality small-cap stocks like Bio-Techne (TECH) to...
Forward Guidance
Forward guidance signal: Headwaters Capital remains cautious of a 1999-style speculative AI bubble, instead deploying capital into deeply discounted, high-quality small-cap stocks like Bio-Techne (TECH) to...
Language Signal
Tone analysis indicates high conviction language: Headwaters Capital remains cautious of a 1999-style speculative AI bubble, instead deploying capital into deeply discounted, high-quality small-cap stocks like Bio-Techne (TECH) to...
Perceived Risk
Perceived risk level is evaluated as high conviction. Headwaters Capital remains cautious of a 1999-style speculative AI bubble, instead deploying capital into deeply discounted, high-quality small-cap stocks like Bio-Techne (TECH) to...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. Headwaters Capital remains cautious of a 1999-style speculative AI bubble, instead deploying capital into deeply discounted, high-quality small-cap stocks like Bio-Techne (TECH) to...
Time Horizon
Investment time horizon reflects a high conviction orientation. Headwaters Capital remains cautious of a 1999-style speculative AI bubble, instead deploying capital into deeply discounted, high-quality small-cap stocks like Bio-Techne (TECH) to...
